A synthetic peptide for use as a blocking control in assays to test for specificity of HADH antibody, Alternative Names: HADH control peptide, HADH antibody Blocking Peptide, Anti-HADH Blocking Peptide, Hydroxyacyl-Coenzyme A Dehydrogenase Blocking Peptide, HAD Blocking Peptide, HADH1 Blocking Peptide, HADHSC Blocking Peptide, HHF4 Blocking Peptide, M/SCHAD Blocking Peptide, MGC8392 Blocking Peptide, SCHAD Blocking Peptide
HADH functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene.